330 related articles for article (PubMed ID: 18536180)
1. Pharmacokinetic monitoring of HIV-1 protease inhibitors in the antiretroviral therapy.
Pawiński T; Pulik P; Gralak B; Horban A
Acta Pol Pharm; 2008; 65(1):93-100. PubMed ID: 18536180
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous determination of the new HIV protease inhibitor lopinavir (ABT 378) and of indinavir(1), amprenavir, saquinavir, ritonavir (ABT 538)(2) and nelfinavir(3) in human plasma by gradient HPLC.
Kuschak D; Mauss S; Schmutz G; Gantke B
Clin Lab; 2001; 47(9-10):471-7. PubMed ID: 11596909
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous determination of 8 HIV protease inhibitors in human plasma by isocratic high-performance liquid chromatography with combined use of UV and fluorescence detection: amprenavir, indinavir, atazanavir, ritonavir, lopinavir, saquinavir, nelfinavir and M8-nelfinavir metabolite.
Verbesselt R; Van Wijngaerden E; de Hoon J
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jan; 845(1):51-60. PubMed ID: 16997640
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous determination of 16 anti-HIV drugs in human plasma by high-performance liquid chromatography.
Notari S; Bocedi A; Ippolito G; Narciso P; Pucillo LP; Tossini G; Donnorso RP; Gasparrini F; Ascenzi P
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):258-66. PubMed ID: 16406832
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography.
Hugen PW; Verweij-van Wissen CP; Burger DM; Wuis EW; Koopmans PP; Hekster YA
J Chromatogr B Biomed Sci Appl; 1999 Apr; 727(1-2):139-49. PubMed ID: 10360433
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of HIV protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
Dickinson L; Robinson L; Tjia J; Khoo S; Back D
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec; 829(1-2):82-90. PubMed ID: 16226495
[TBL] [Abstract][Full Text] [Related]
7. [Simultaneous quantitative determination of amprenavir and indinavir in human plasma by high-performance liquid chromatography].
Laussine S; Roux A; Delhotal-Landes B; Flouvat B
Ann Biol Clin (Paris); 2001; 59(2):169-75. PubMed ID: 11282520
[TBL] [Abstract][Full Text] [Related]
8. Rapid quantification of HIV protease inhibitors in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
Crommentuyn KM; Rosing H; Nan-Offeringa LG; Hillebrand MJ; Huitema AD; Beijnen JH
J Mass Spectrom; 2003 Feb; 38(2):157-66. PubMed ID: 12577282
[TBL] [Abstract][Full Text] [Related]
9. Simple and simultaneous determination of the hiv-protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir plus M8 nelfinavir metabolite and the nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma by reversed-phase liquid chromatography.
Poirier JM; Robidou P; Jaillon P
Ther Drug Monit; 2005 Apr; 27(2):186-92. PubMed ID: 15795650
[TBL] [Abstract][Full Text] [Related]
10. Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlations.
Lafeuillade A; Solas C; Halfon P; Chadapaud S; Hittinger G; Lacarelle B
HIV Clin Trials; 2002; 3(1):27-35. PubMed ID: 11819183
[TBL] [Abstract][Full Text] [Related]
11. Lopinavir/ritonavir combined with twice-daily 400 mg indinavir: pharmacokinetics and pharmacodynamics in blood, CSF and semen.
Isaac A; Taylor S; Cane P; Smit E; Gibbons SE; White DJ; Drake SM; Khoo S; Back DJ
J Antimicrob Chemother; 2004 Aug; 54(2):498-502. PubMed ID: 15254024
[TBL] [Abstract][Full Text] [Related]
12. Intracellular and plasma pharmacokinetics of nelfinavir and M8 in HIV-infected patients: relationship with P-glycoprotein expression.
Ford J; Cornforth D; Hoggard PG; Cuthbertson Z; Meaden ER; Williams I; Johnson M; Daniels E; Hsyu P; Back DJ; Khoo SH
Antivir Ther; 2004 Feb; 9(1):77-84. PubMed ID: 15040539
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic interactions between HIV-1 protease inhibitors in rats: study on combinations of two kinds of HIV-1 protease inhibitors.
Shibata N; Matsumura Y; Okamoto H; Kawaguchi Y; Ohtani A; Yoshikawa Y; Takada K
J Pharm Pharmacol; 2000 Oct; 52(10):1239-46. PubMed ID: 11092568
[TBL] [Abstract][Full Text] [Related]
14. Maternal-fetal transfer and amniotic fluid accumulation of protease inhibitors in pregnant women who are infected with human immunodeficiency virus.
Chappuy H; Tréluyer JM; Rey E; Dimet J; Fouché M; Firtion G; Pons G; Mandelbrot L
Am J Obstet Gynecol; 2004 Aug; 191(2):558-62. PubMed ID: 15343237
[TBL] [Abstract][Full Text] [Related]
15. An isocratic liquid chromatography method for determining HIV non-nucleoside reverse transcriptase inhibitor and protease inhibitor concentrations in human plasma.
Weller DR; Brundage RC; Balfour HH; Vezina HE
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):369-73. PubMed ID: 17081812
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of two randomized trials evaluating the safety and efficacy of indinavir, saquinavir and lopinavir in combination with low-dose ritonavir: the MaxCmin1 and 2 trials.
Justesen US; Fox Z; Pedersen C; Cahn P; Gerstoft J; Clumeck N; Losso M; Peters B; Obel N; Castagna A; Dragsted UB; Lundgren JD;
Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):339-44. PubMed ID: 17910618
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous determination of the six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir, and saquinavir) plus M8 nelfinavir metabolite and the nonnucleoside reverse transcription inhibitor efavirenz in human plasma by solid-phase extraction and column liquid chromatography.
Poirier JM; Robidou P; Jaillon P
Ther Drug Monit; 2002 Apr; 24(2):302-9. PubMed ID: 11897976
[TBL] [Abstract][Full Text] [Related]
18. Development of a chromatographic method for the determination of saquinavir in plasma samples of HIV patients.
Campanero MA; Escolar M; Arangoa MA; Sádaba B; Azanza JR
Biomed Chromatogr; 2002 Feb; 16(1):7-12. PubMed ID: 11816005
[TBL] [Abstract][Full Text] [Related]
19. High-performance liquid chromatography assay for the quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma.
Rezk NL; Tidwell RR; Kashuba AD
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(2):241-7. PubMed ID: 15135096
[TBL] [Abstract][Full Text] [Related]
20. High-performance liquid chromatographic method for the simultaneous determination of the six HIV-protease inhibitors and two non-nucleoside reverse transcriptase inhibitors in human plasma.
Titier K; Lagrange F; Péhourcq F; Edno-Mcheik L; Moore N; Molimard M
Ther Drug Monit; 2002 Jun; 24(3):417-24. PubMed ID: 12021635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
